Patent Eligibility and Engineered Natural Products
Overcoming 101 Challenges, Leveraging Options to Obtain IP Protection
Recording of a 90-minute premium CLE webinar with Q&A
This CLE webinar will guide patent counsel on patent eligibility issues with engineered natural products. The panel will examine the key considerations in determining patentability and review recent case law. The panel will also address alternatives for getting IP protection for engineered natural products.
Outline
- Determining if product is patentable—key considerations
- Recent cases and what they mean for patentability of engineered natural products
- Other options for protecting IP rights in engineered natural products
- Method claims
- Product by process claims
- Trade secrets
- Others
Benefits
The panel will review these and other relevant issues:
- What are the hurdles for patent counsel to demonstrate an engineered natural product is patentable?
- How can patent counsel meet the requirements under §101 in patent applications for engineered natural products?
- What steps should patent counsel take to minimize the likelihood of §101 rejections?
Faculty
Virginia L. Carron
Partner
Finnegan Henderson Farabow Garrett & Dunner
Ms. Carron practices patent and trademark litigation and counseling. Her broad client base includes a large food and... | Read More
Ms. Carron practices patent and trademark litigation and counseling. Her broad client base includes a large food and beverage company; a company involved in refining, chemicals and biofuels, forest and consumer products, fertilizers, polymers and fibers, and numerous international clients in various fields. Her litigation experience includes numerous U.S. district court trials, trials before the U.S. International Trade Commission, and appeals to the U.S. Court of Appeals for the Federal Circuit. She counsels clients on IP licensing and related transactional matters in both trademarks and patents for several Fortune 500 companies.
Close
Jessica L.A. Marks
Atty
Finnegan Henderson Farabow Garrett & Dunner
Ms. Marks focuses her practice on patent prosecution and litigation related to many technologies, including... | Read More
Ms. Marks focuses her practice on patent prosecution and litigation related to many technologies, including biotechnology and pharmaceuticals. She drafts applications and coordinates the prosecution of U.S. and foreign applications. Ms. Marks has been involved in various aspects of litigation before U.S. district courts, including Abbreviated New Drug Application (ANDA) litigations under the Hatch-Waxman Act, as well as proceedings before the U.S. International Trade Commission (ITC).
Close
Erin M. Sommers, Ph.D.
Partner
Finnegan Henderson Farabow Garrett & Dunner
Dr. Sommers helps clients protect their IP rights at every stage, from strategic counseling and procuring patents... | Read More
Dr. Sommers helps clients protect their IP rights at every stage, from strategic counseling and procuring patents before the USPTO to representing clients in proceedings before the PTAB and federal courts. She focuses her practice on Abbreviated New Drug Application (ANDA) litigation, post-grant proceedings, and counseling, primarily in the chemical and pharmaceutical areas. Her litigation experience ranges from pre-litigation analyses through trial and on to appeals. She routinely represents patentees and petitioners in post-grant proceedings. In her prosecution practice, she assists clients with global management of their patent portfolios.
Close